Carcinoma, Squamous Cell: all 1,779 studies
Page 1 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.
- Cemiplimab and Quad Shot Radiation for Cutaneous Squamous Cell Carcinoma in the Head and NeckRecruitingNCT07869823Early Phase 1
- Screening Psychosocial Distress in Head and Neck CancerNot yet recruitingNCT07851818
- Hair Regrowth Following Partial Thickness Removal of SSCISNot yet recruitingNCT07809191Not applicable
- Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation StudyNot yet recruitingNCT07778056
- Two-photon Fluorescence Microscopy of Dermatologic BiopsiesRecruitingNCT07773688Not applicable
- CLEAR (Cervical Lymphatic Exclusion in Adjuvant Radiation)RecruitingNCT07755449Phase 2
- Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell CarcinomaRecruitingNCT07741643Phase 1
- Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)RecruitingNCT07741565Early Phase 1
- Impact of Dysport on PMFF Donor ScarNot yet recruitingNCT07720726Phase 4
- Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic BiopsiesRecruitingNCT07682831Not applicable
- Tisotumab Vedotin in Squamous Cell Carcinoma of the VulvaNot yet recruitingNCT07672782Phase 2
- Phase 1 Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant LesionsNot yet recruitingNCT07631013Phase 1
- Effects of Infusion Timing on Treatment Response in Solid TumorsRecruitingNCT07630168Phase 2
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid TumorsRecruitingNCT07628634Early Phase 1
- A Study of IDP-001 in Advanced or Metastatic Solid TumorsRecruitingNCT07602842Phase 1/2
- AI-Assisted Endoscopy for Upper Aerodigestive Tract LesionsNot yet recruitingNCT07596355
- Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCsNot yet recruitingNCT07578467Phase 1/2
- Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)Not yet recruitingNCT07552558Phase 1/2
- Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)RecruitingNCT07513389Phase 2
- Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)RecruitingNCT07460765Phase 1
- Intra-lesional Tumor Boost for Bulky Cervical CancerRecruitingNCT07435376Phase 2
- 5-Fluorouracil Response and Optimization STudy (The FROST Trial)RecruitingNCT07419464Phase 2
- Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.RecruitingNCT07417605
- INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)RecruitingNCT07403630Not applicable
- Correlation of Dermoscopic Findings With Histopathological Features and Invasion Depth in Cutaneous Squamous Cell CarcinomaNot yet recruitingNCT07384949
- Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor RecurrenceNot yet recruitingNCT07361666
- Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell CancerNot yet recruitingNCT07361133Phase 2
- A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and NeckNot yet recruitingNCT07346196Phase 2
- Intratumoral N17350 in Advanced Solid TumorsRecruitingNCT07339176Phase 1/2
- Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for RadiotherapyEnrolling by invitationNCT07311057Phase 3
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
- Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin CancerRecruitingNCT07257094
- Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)RecruitingNCT07241585Not applicable
- Patient Preference for Subcutaneous vs. Intravenous Immune TherapyRecruitingNCT07223424Phase 2
- Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell CarcinomaRecruitingNCT07217028Phase 1
- PDT For Induction Therapy For Head And Neck CancerRecruitingNCT07214987Phase 2
- Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)RecruitingNCT07209189Phase 2
- Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch SyndromeRecruitingNCT07201012Not applicable
- Head and Neck Cancer Omics/Integrated Precision Medicine (HOPE)RecruitingNCT07190573
- Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell CarcinomaNot yet recruitingNCT07127614
- A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsRecruitingNCT07115043Phase 1/2
- Defining TRPV4 Contribution of Schwann Cells to Oral Cancer PainRecruitingNCT07095608Not applicable
- Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure ProphylaxisRecruitingNCT07029152Not applicable
- A Prospective Single-Arm Study（NCLDR）Not yet recruitingNCT07028918Early Phase 1
- Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous CarcinomaNot yet recruitingNCT07019181Phase 2
- Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive ChemoradiotherapyEnrolling by invitationNCT07016737Phase 3
- Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell CancerRecruitingNCT07016724Phase 2
- Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin OintmentRecruitingNCT07010692Phase 1/2
- Prospective Data Collection Initiative on Thoracic MalignanciesRecruitingNCT06996249
- Discontinuation of Tobacco Dependence in Smoking Patients With Squamous Cell Carcinoma of the Head-neck District: Multicenter Prospective Observational StudyNot yet recruitingNCT06995417
- Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell CarcinomaRecruitingNCT06988956Phase 2
- SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06979986Not applicable
- Toripalimab With Chemotherapy for Sinus CancerRecruitingNCT06940180Phase 2
- High-Resolution PET-CT Imaging for Surgical Margin VisualizationRecruitingNCT06915454Not applicable
- Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCCRecruitingNCT06912087Phase 1
- In Vitro Study of [18F]F-FAPI-74 Feasibility in Vulvar CancerNot yet recruitingNCT06911801
- An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)AvailableNCT06910137
- Neoadjuvant QL1706 Therapy for ESCCRecruitingNCT06908382Phase 2
- A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCRecruitingNCT06908304Phase 3
- Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT06907602Phase 2/3
- Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker AnalysisRecruitingNCT06905145
- Toripalimab Adjuvant Therapy in Subjects With Resected Esophageal Squamous Cell Carcinoma Who Achieved Pathological Complete Response (pCR)Not yet recruitingNCT06903871Phase 2
- The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCCNot yet recruitingNCT06895369Phase 2
- A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell CarcinomaNot yet recruitingNCT06894459Phase 2
- Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational StudyRecruitingNCT06879964
- Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCCRecruitingNCT06876844Phase 2
- Safety and Efficacy Trial of TV5M01 for Radiation-Induced Mucositis in Head and Neck Cancer Patients.Not yet recruitingNCT06875791Phase 1/2
- Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19.RecruitingNCT06869473Phase 2
- Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCCNot yet recruitingNCT06861894Phase 2
- Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCCNot yet recruitingNCT06861777Phase 2/3
- Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal CancerNot yet recruitingNCT06861712Phase 2
- Heterogeneity of Oral Squamous Cell Carcinoma Analysis by Single Cell RNA SequencingNot yet recruitingNCT06861036Not applicable
- QL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Resectable Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06852456Phase 2
- A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell CarcinomaRecruitingNCT06843889Phase 2
- Exercise Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)Not yet recruitingNCT06839014Not applicable
- Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal ReconstructionRecruitingNCT06831149Phase 2
- Towards Cure Via Only Ultra-short ICB in CSCCRecruitingNCT06823479Phase 2
- Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck CancerRecruitingNCT06819228Phase 1
- Reconstruction of Cervical Lymphatic System During Head and Neck Squamous Cell Carcinoma SurgeryNot yet recruitingNCT06815705Not applicable
- Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06814067Phase 2
- Drug Screening of Cutaneous Lesions of Squamous Cell CarcinomaEnrolling by invitationNCT06782399Early Phase 1
- To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)RecruitingNCT06772454
- Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery.Not yet recruitingNCT06772428Phase 3
- Hypofractionated Radiotherapy for HNSCC in Elderly PatientsEnrolling by invitationNCT06768125Not applicable
- Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell CarcinomaNot yet recruitingNCT06759155Phase 2
- Safety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06756841Not applicable
- Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any HistotypeRecruitingNCT06753136Not applicable
- Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCCRecruitingNCT06752798Phase 2
- Intratumoral Lidocaine Injection Before Oropharyngeal Cancer SurgeryRecruitingNCT06747390Phase 1
- Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs TherapyNot yet recruitingNCT06746961Phase 1/2
- Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and NeckRecruitingNCT06744296
- Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck CancerRecruitingNCT06736379Phase 1
- Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB SkinRecruitingNCT06731933Phase 2
- Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell CarcinomaNot yet recruitingNCT06728618Phase 2
- The Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCCRecruitingNCT06727162
- Efficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients With Stable Disease After Two Treatment Courses: A Single-Arm Exploratory StudyNot yet recruitingNCT06722495Not applicable
- Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT06718205Phase 2
- Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell CarcinomaEnrolling by invitationNCT06715501Not applicable
- Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06714266Phase 2
- Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 MethylationNot yet recruitingNCT06713655